Sindrome coronarica acuta: l’Enoxaparina efficace quanto l’Eparina non-frazionata
Lo studio SYNERGY ( Superior Yield of the New Strategy of Enoxaparin, Revascularization, and Glycoprotein IIb/IIIa Inhibitors ) ha dimostrato che l’Enoxaparina ( Clexane ) è efficace quanto l’Eparina ... leggi